NCT01820221

Brief Summary

This is a randomized prospective clinical trial designed to determine the wound complication rates for stainless steel staples versus subcuticular suture for skin closure in the obese parturient (BMI≥ 30kg/m2) undergoing cesarean delivery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Mar 2013

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

March 19, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 28, 2013

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

February 3, 2017

Status Verified

February 1, 2017

Enrollment Period

3.9 years

First QC Date

March 19, 2013

Last Update Submit

February 2, 2017

Conditions

Keywords

cesarean deliverywound complicationsskin closure methods

Outcome Measures

Primary Outcomes (1)

  • Wound complication rates

    Wound complications will be classified as minor and major and the major complications will be further stratified as Seroma, Hematoma and Wound Infection/Surgical site infection (SSI). 1. Minor wound disruption: any wound disruption that DOES not require that the incision be opened, evacuated, irrigated or debrided. There is no evidence of infection including erythema, induration or purulent material. No antibiotic therapy is given. 2. Major wound disruption requires that incision be opened, evacuated, and or irrigated or debrided and includes: * Seroma: collection of serous fluid in the wound without evidence of infection * Hematoma: Demonstrable blood clot between the rectus fascia and the skin * Infection: Any wound that drains purulent material and shows at least 2 of the classic signs of infection; induration, erythema, tenderness, fever. Wound infections will be further classified as superficial or deep.

    6 weeks postpartum

Secondary Outcomes (1)

  • Post-operative pain

    72 hours postpartum

Study Arms (2)

Arm 1: Skin closure with suture

ACTIVE COMPARATOR

Subjects in this group will be randomized to suture for skin closure with computer generated random card draw.

Procedure: Suture vs. staples closure method after c-section in obese women.

Arm 2: Skin closure with staples

ACTIVE COMPARATOR

Subjects randomized to skin closure with staples with computer generated random card draw.

Procedure: Suture vs. staples closure method after c-section in obese women.

Interventions

Random card draw to either suture skin closure or staple skin closure arm of study.

Arm 1: Skin closure with sutureArm 2: Skin closure with staples

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years or older
  • BMI ≥ 30kg/m2 on admission to labor and delivery
  • Patient is for scheduled cesarean delivery or in non-emergent labor but has an indication for cesarean delivery
  • Singleton pregnancies
  • Gestational age ≥ 24weeks
  • Cesarean delivery performed under regional anesthesia

You may not qualify if:

  • Refusal to participate
  • BMI \< 30kg/m2
  • \< 24 weeks gestation
  • Intrauterine fetal demise
  • Chronic pain syndrome requiring chronic narcotic use
  • Emergent clinical situations which preclude obtaining informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mary L Racher, MD

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2013

First Posted

March 28, 2013

Study Start

March 1, 2013

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

February 3, 2017

Record last verified: 2017-02

Locations